2021-01-07,Adamas to Present at Upcoming ICR Conference
2021-01-05,Would Shareholders Who Purchased Adamas Pharmaceuticals' (NASDAQ:ADMS) Stock Three Years Be Happy With The Share price Today?
2021-01-05,Adamas Completes Acquisition of OSMOLEX ER®
2021-01-04,Adamas to Present at Upcoming H.C. Wainwright Conference
2020-12-11,Is ADMS A Good Stock To Buy Now?
2020-12-11,Adamas Announces New Employment Inducement Grant
2020-12-02,Adamas Announces Agreement to Amend Royalty-Backed Loan Agreement with HealthCare Royalty Partners
2020-12-02,Adamas Announces Agreement to Settle Patent Litigation with Osmotica
2020-11-24,Adamas to Present at Upcoming Evercore ISI Conference
2020-11-23,Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg
2020-11-18,Adamas to Present at Upcoming Piper Sandler Conference
2020-11-13,Adamas Announces New Employment Inducement Grant
2020-11-07,"Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?"
2020-11-05,"Adamas Pharmaceuticals (ADMS) Reports Q3 Loss, Misses Revenue Estimates"
2020-11-05,Adamas Reports Third Quarter 2020 Financial Results
2020-11-02,Adamas announces settlement agreement of previously disclosed class action litigation
2020-10-29,Adamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2020-10-26,"Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020"
2020-10-09,Adamas Announces New Employment Inducement Grant
2020-10-01,"Adamas appoints new Chief Medical Officer, Adrian Quartel, MD"
2020-09-11,Adamas Announces New Employment Inducement Grant
2020-09-11,Adamas presents new post-hoc data analysis for GOCOVRI® in Parkinsons disease patients with dyskinesia at the 2020 Movement Disorder Society Virtual Congress
2020-09-08,Adamas to Present at Upcoming HC Wainwright Conference
2020-09-01,Adamas Appoints Anna Richo to Board of Directors
2020-08-21,"What Kind Of Shareholders Own Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)?"
2020-08-14,Adamas Announces New Employment Inducement Grant
2020-08-11,Is Adamas Stock Still Worth Buying After Its 77% Rally? This 5-Star Analyst Says Yes
2020-08-06,Adamas Reports Second Quarter 2020 Financial Results
2020-07-30,Will Adamas Pharmaceuticals (ADMS) Report Negative Earnings Next Week? What You Should Know
2020-07-23,"Adamas to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020"
2020-07-15,Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI® in Parkinsons disease at the 2020 American Academy of Neurology (AAN) Science Highlights Platform
2020-07-10,Adamas Announces New Employment Inducement Grant
2020-06-18,"The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions"
2020-06-17,Adamas provides program update for ADS-5102 for multiple sclerosis patients with walking impairment
2020-06-05,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid"
2020-06-04,Adamas announces FDA filing acceptance of sNDA to modify the indication statement for GOCOVRI® to include treatment for Parkinsons disease patients receiving levodopa and experiencing OFF episodes
2020-06-03,Adamas to Present at Upcoming William Blair Conference
2020-05-20,Edited Transcript of ADMS earnings conference call or presentation 7-May-20 9:00pm GMT
2020-05-13,Adamas announces issuance of new U.S. patent for GOCOVRI in Parkinsons disease - expands coverage with reduction of OFF time and increased good ON time
2020-05-08,Adamas Announces New Employment Inducement Grant
2020-05-07,Adamas Reports First Quarter 2020 Financial Results
2020-04-30,Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
2020-04-28,All You Need to Know About Adamas (ADMS) Rating Upgrade to Buy
2020-04-27,"Adamas to Announce First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020"
2020-04-10,Adamas Announces New Employment Inducement Grant
2020-03-23,"Adamas Pharmaceuticals Stock  Kehoe Law Firm, P.C. Investigating Breach of Fiduciary Duty Claims on Behalf of ADMS Investors  ADMS Shareholders Encouraged to Contact Kehoe Law Firm, P.C."
2020-03-20,Generic Drugs Industry's Prospects Uncertain Amid Coronavirus
2020-03-19,"Adamas Pharmaceuticals Stock - Kehoe Law Firm, P.C. Investigating Breach of Fiduciary Duty Claims on Behalf of ADMS Investors - ADMS Shareholders Encouraged to Contact Kehoe Law Firm, P.C."
2020-03-10,Edited Transcript of ADMS earnings conference call or presentation 25-Feb-20 9:30pm GMT
2020-03-06,Adamas Announces New Employment Inducement Grant
2020-02-28,"Earnings Update: Here's Why Analysts Just Lifted Their Adamas Pharmaceuticals, Inc. Price Target To US$12.69"
2020-02-25,"Adamas Pharmaceuticals (ADMS) Reports Q4 Loss, Tops Revenue Estimates"
2020-02-25,Adamas Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-24,Cronos (CRON) to Report Q4 Earnings: What's in the Cards?
2020-02-20,Adamas to Present at Upcoming Healthcare Conferences
2020-02-19,"Adamas to Announce Fourth Quarter 2019 Financial Results and Host Conference Call on February 25, 2020"
2020-02-13,Adamas To Present Analysis of Clinical Trials on GOCOVRI® Treatment at the 3rd Pan American Parkinsons Disease and Movement Disorders Congress
2020-02-12,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data"
2020-02-11,Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinsons Disease
2020-02-10,SHAREHOLDER ALERT: ADMS GDOT BYND: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
2020-02-10,"ADMS FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action  ADMS"
2020-02-10,"FINAL DEADLINE ALERT - Adamas Pharmaceuticals, Inc. (ADMS) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020"
2020-02-09,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, OPRA and PTLA"
2020-02-08,"ADMS FINAL DEADLINE: ROSEN, INVESTOR COUNSEL, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10 Deadline in Securities Class Action - ADMS"
2020-02-07,"CLASS ACTION UPDATE for ADMS, GDOT and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"
2020-02-07,"DEADLINE ALERT - Adamas Pharmaceuticals, Inc. (ADMS) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020"
2020-02-06,"CLASS ACTION UPDATE for ADMS, SSL and BZUN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"
2020-02-06,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS"
2020-02-05,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, GDOT and FSCT"
2020-02-05,"5-Day Deadline Alert: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2020-02-05,"The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, XYF and PTLA"
2020-02-05,"ADAMAS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc.s January 24, 2018 Secondary Public Offering To Contact The Firm"
2020-02-05,"CLASS ACTION UPDATE for ADMS, FSCT and BYND: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"
2020-02-05,"DEADLINE ALERT - Adamas Pharmaceuticals, Inc. (ADMS) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020"
2020-02-04,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, FSCT and PTLA"
2020-02-04,"6-Day Deadline Alert: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2020-02-04,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS"
2020-02-04,SHAREHOLDER ALERT: ADMS PTLA GERN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
2020-02-04,"Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc."
2020-02-04,"INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines"
2020-02-04,"ADMS INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of a Filing Deadline in a Securities Class Action Against Adamas Pharmaceuticals, Inc"
2020-02-03,SHAREHOLDER ALERT: ADMS GDOT PTLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
2020-02-03,"NOTICE FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2020-02-03,"DEADLINE ALERT for XYF, BZUN, ADMS, MHK: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders"
2020-02-03,"The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, GDOT and XYF"
2020-02-03,"ADMS INVESTOR DEADLINE IN 7 DAYS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Adamas Pharmaceuticals, Inc."
2020-02-01,"ADMS INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Adamas Pharmaceuticals, Inc."
2020-02-01,"ADMS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action  ADMS"
2020-01-31,SHAREHOLDER ALERT: ADMS MMSI OPRA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
2020-01-31,"INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines"
2020-01-31,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS"
2020-01-31,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS"
2020-01-31,"CLASS ACTION UPDATE for ADMS, FCAU and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"
2020-01-31,"ADAMAS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm"
2020-01-31,"The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, MMSI and FCAU"
2020-01-31,"INVESTOR ALERT: ADMS and BZUN: Bronstein, Gewirtz & Grossman LLC Alerts Shareholders With Losses Exceeding $100K of Class Action Deadlines"
2020-01-30,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, EXC and QD"
2020-01-29,"ALERT FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2020-01-29,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS"
2020-01-29,"ADAMAS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm"
